The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients.
 
Neil Howard Segal
Honoraria - MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Imugene; Kyocera; Macrogenics; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Pfizer; Roche/Genentech
 
Nancy E. Kemeny
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Baxter; Bayer
Research Funding - Bayer
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Novartis
 
Pamela Joan Raasch
No Relationships to Disclose
 
Peter Warren
No Relationships to Disclose
 
Anastasia E. Hrabovsky
No Relationships to Disclose
 
Naomi Campbell
No Relationships to Disclose
 
Jinru Shia
No Relationships to Disclose
 
Karyn A. Goodman
Consulting or Advisory Role - Pfizer
 
Joseph Patrick Erinjeri
No Relationships to Disclose
 
Stephen Barnett Solomon
Leadership - Devicor Medical Products
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - AngioDynamics; Covidien; GE Healthcare
Research Funding - GE Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - GE Healthcare-patents pending (Inst)
 
Yoshiya Yamada
No Relationships to Disclose
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I); Roche/Genentech
Research Funding - Taiho Pharmaceutical